UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~ Section 13 OR 15(d) of the Securities Exchange Act of 1934

OFDate ~~THE~~of ~~SECURITIES~~Report ~~EXCHANGE~~(Date ~~ACT~~of OFearliest ~~1934~~event reported): December 16, 2025

Date of Report (Date of earliest event reported): December 4, 2025

Owens & Minor, Inc.

(Exact name of ~~Registrant~~registrant as specified in its charter)

Virginia		001-09810		54-1701843
(State or other jurisdictionof incorporation)		(Commissionfile number)		(I.R.S. employeridentification no.)

10900 Nuckols Road, Suite 400

Glen Allen, Virginia		23060
Virginia	001-09810	54-1701843
(Address of principal executive offices)		(Zip code)
(State or other jurisdiction of	(Commission	(I.R.S. Employer
incorporation or organization)	File Number)	Identification No.)

10900 Nuckols Road, Suite 400,Glen Allen, Virginia		23060
(Address of principal executive
offices)		(Zip Code)

Post Office Box 27626,
Richmond, Virginia		23261-7626
(Mailing address of principal
executive offices)		(Zip Code)

Post Office Box 27626,
Richmond, Virginia		23261-7626
(Mailing address of principal executive offices)		(Zip code)

Registrant’s telephone number, including area code (804) 723-7000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		TradingSymbol(s)		Name of each exchangeon which registered
Common Stock, $2 par value per share		OMI		New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $2 par value per share	OMI	New York Stock Exchange

~~☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)~~

☐Check ~~Soliciting~~the ~~material~~appropriate ~~pursuant~~box tobelow ~~Rule~~if ~~14a~~the Form 8-12K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the ~~Exchange~~following ~~Act~~provisions (17see ~~CFR~~General ~~240~~Instruction A.~~14a-12~~2.below):

~~☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))~~

☐Written ~~Pre-commencement~~ communications pursuant to Rule ~~13e-4(c)~~425 under the ~~Exchange~~Securities Act (17 CFR ~~240~~230.~~13e-4(c~~425))

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Appointment of Perry A. Bernocchi as Executive Vice President, Chief Operating Officer~~

OnItem ~~December 4, 2025, Owens & Minor, Inc~~5.02 ~~(the~~Departure ~~“Company”)~~of ~~appointed~~Directors ~~Perry~~or A.Certain ~~Bernocchi,~~Officers; ~~age~~Election ~~67,~~of ~~Executive~~Directors; ~~Vice~~Appointment ~~President, Chief Operating Officer~~ of ~~the~~Certain ~~Company,~~Officers; ~~effective~~Compensatory ~~December 5,~~Arrangements ~~2025. Since March 2023, Mr. Bernocchi has served as Executive Vice President and Chief Executive Officer~~ of ~~the~~Certain ~~Company’s Patient Direct segment~~Officers. Biographical information regarding Mr. Bernocchi is set forth in the Company’s annual report on Form 10-K, filed with the U.S. Securities and Exchange Commission on February 28, 2025, and such information is incorporated by reference herein.

~~Mr. Bernocchi’s~~On ~~compensation~~December ~~and~~16, 2025, the ~~terms~~board of ~~his~~directors ~~employment~~of ~~with~~Owens ~~the~~& ~~Company remain unchanged. Mr. Bernocchi is not a party to any transaction~~Minor, ~~and there is no currently proposed transaction with Mr~~Inc. ~~Bernocchi,~~ ~~that~~(the is“Company”) ~~required~~approved toan beamendment ~~disclosed~~(the ~~pursuant~~“Amendment”) to ~~Item~~the ~~404(a)~~Owens of& ~~Regulation~~Minor, ~~S-K~~Inc. ~~There~~Executive ~~are~~Deferred noCompensation ~~family relationships between Mr. Bernocchi~~ and ~~any~~Retirement ofPlan (the ~~Company’s~~“EDCRP”), ~~directors~~to orfreeze ~~executive~~participation ~~officers.~~and ~~Mr. Bernocchi~~all iscontributions ~~not~~under athe ~~party~~EDCRP tofor ~~any~~all ~~arrangement~~participants, oreffective ~~understanding regarding his selection~~ as anof ~~officer~~January 1, 2026.

The foregoing description of the Amendment is only a summary and is qualified in its entirety by the Amendment, a copy of which will be filed with the Company’s Annual Report on Form 10-K for the year ending December 31, 2025.

Item 7.01. Regulation FD Disclosure.

~~Effective~~On December 31 18, 2025, ~~Jennifer~~the ~~Stone,~~Company ~~Executive~~issued ~~Vice~~a ~~President,~~press ~~Chief~~release ~~Human~~announcing ~~Resources~~that ~~Officer~~the ~~(CHRO),~~Company will ~~leave~~be ~~the~~changing ~~Company.~~its ~~Upon~~name Msto Accendra Health, Inc. ~~Stone~~ and that the Company’s ~~departure,~~New York Stock Exchange ticker symbol will change to “ACH.” It is currently anticipated that the ~~CHRO~~name ~~position~~change will be ~~eliminated~~effective on or about December 31, 2025 and ~~Heath~~trading ~~Galloway,~~under ~~Executive~~the ~~Vice~~new ~~President,~~name ~~General~~and ~~Counsel &~~symbol ~~Corporate~~will ~~Secretary~~begin on or about January 2, ~~will~~2026. ~~add~~The ~~oversight~~Company ofis furnishing the ~~human~~press ~~resources~~release ~~function~~attached tohereto ~~his~~as ~~current~~Exhibit ~~responsibilities~~99.1 pursuant to Item 7.01 of Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01.	Financial Statements and Exhibits.

(d) Exhibits.



Exhibit Number		Exhibit Title or Description

99.1		Press Release of the Company, dated December 18, 2025 (furnished pursuant to Item 7.01).

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.

~~Date: December 8, 2025~~

~~Owens & Minor, Inc. By: /s/ Heath Galloway Name: Heath Galloway Title: Executive Vice President, General Counsel and Corporate Secretary~~


	OWENS & MINOR, INC.

Date: December 18, 2025	By:	/s/ Heath H. Galloway
	Name:		Heath H. Galloway
	Title:		Executive Vice President, General Counsel and Corporate Secretary

Filing Compare · ACCENDRA HEALTH INC/VA/